CATALYST PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Catalyst Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q4 2024.
  • Catalyst Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $62.8M, a 50.7% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was $195M, a 125% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was $195M, a 125% increase from 2023.
  • Catalyst Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was $86.8M, a 14.8% decline from 2022.
  • Catalyst Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was $102M, a 94.4% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $195M $62.8M +$21.2M +50.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-26
Q3 2024 $174M $50.9M +$88.1M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $85.9M $54.2M +$7.55M +16.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $78.3M $27.1M -$8.48M -23.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $86.8M $41.7M +$10.9M +35.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-26
Q3 2023 $75.9M -$37.2M -$62.3M -248% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $138M $46.7M +$18.1M +63.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $120M $35.6M +$18.2M +105% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $102M $30.8M +$18.1M +142% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-26
Q3 2022 $83.8M $25.1M +$11.1M +79.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $72.7M $28.6M +$12.7M +80.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $60M $17.4M +$7.57M +77.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $52.4M $12.7M +$4.13M +47.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $48.3M $14M +$2.3M +19.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $46M $15.8M +$5.56M +54% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $40.4M $9.8M -$899K -8.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $41.3M $8.62M +$610K +7.62% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 $40.7M $11.7M -$2.14M -15.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $42.8M $10.3M -$677K -6.18% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $43.5M $10.7M +$11.7M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $31.8M $8.01M +$22.8M Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 $8.97M $13.8M +$22M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$13.1M $11M +$17.3M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$30.3M -$988K +$4.95M +83.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$35.3M -$14.8M -$9.33M -169% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$26M -$8.18M -$3.88M -90% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$22.1M -$6.34M -$2.15M -51.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$19.9M -$5.93M -$1.25M -26.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$18.7M -$5.51M -$1.2M -27.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$17.5M -$4.31M -$393K -10% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$17.1M -$4.18M +$633K +13.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$17.7M -$4.68M +$1.56M +25% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$19.3M -$4.31M +$1.88M +30.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$21.2M -$3.91M +$1.1M +22% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-14
Q2 2016 -$22.3M -$4.81M +$82.9K +1.69% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-14
Q1 2016 -$22.3M -$6.24M -$1.95M -45.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-14
Q4 2015 -$20.4M -$6.19M -$2.21M -55.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$18.2M -$5.02M -$908K -22.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$17.3M -$4.9M -$1.91M -63.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 -$15.4M -$4.29M -$784K -22.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$14.6M -$3.98M -$1.28M -47.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$13.3M -$4.11M -$863K -26.6% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$12.5M -$2.99M -$337K -12.7% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$12.1M -$3.51M -$1.8M -106% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$10.3M -$2.71M -$1.2M -79.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$9.11M -$3.25M -$1.96M -153% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 -$7.15M -$2.65M -$1.59M -149% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 -$5.56M -$1.71M -$341K -25% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-13
Q4 2012 -$5.22M -$1.51M +$529K +26% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-19
Q3 2012 -$5.75M -$1.28M -$153K -13.5% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-19
Q2 2012 -$5.6M -$1.07M +$330K +23.6% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-19
Q1 2012 -$5.93M -$1.36M +$155K +10.2% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-19
Q4 2011 -$6.08M -$2.03M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 -$1.13M -$223K -24.5% Jul 1, 2011 Sep 30, 2011 10-K 2013-04-01
Q2 2011 -$1.4M -$64.3K -4.83% Apr 1, 2011 Jun 30, 2011 10-K 2013-04-01
Q1 2011 -$1.52M Jan 1, 2011 Mar 31, 2011 10-K 2013-04-01
Q3 2010 -$908K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.33M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.